Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Scientists To Conduct TCM Research

This article was originally published in PharmAsia News

Executive Summary

Stephen Minger, Director of the Stem Cell Biology Laboratory at King's College London and senior lecturer at Wolfson Centre for Age Related Diseases, has lately been making frequent trips to China to conduct TCM research. At a recent Sino-UK biomedical innovation seminar in Shanghai, Minger expresses confidence in the effectiveness of TCM. He is collaborating with relevant Chinese institutions to screen local herbal extracts t have stimulating effect on brain cells to identify the active components. However, he notes that the functional, biological and chemical reactivity mechanisms of most Chinese medicines remain unclear, critical factors that hinder TCM's international recognition. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068878

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel